Minoxidil 50 MG/ML Topical Foam — RxCUI 645146
RxNorm drug concept · Semantic clinical drug
RxCUI 645146
Semantic clinical drug · SCD
● Current RxNorm concept 73 FDA products
121 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI645146
Official nameMinoxidil 50 MG/ML Topical Foam
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asminoxidil 5 % Topical Foam
FDA products mapped73
Package NDCs mapped121
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Minoxidil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a really common question. Minoxidil tablets are very effective at lowering blood pressure, but they cause two side effects that need to be managed: your heart speeds up, and...
- I've been prescribed minoxidil tablets for blood pressure — why do I need to take other pills with it?
- It takes patience — most people need at least 2 to 4 months of twice-daily use before they notice any regrowth. Some products note that results can start appearing around the 2-mon...
- I'm using a topical minoxidil solution for hair loss. How long before I see results?
🕸️ Concept Web — How Minoxidil 50 MG/ML Topical Foam Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Minoxidil 50 MG/ML Topical Foam
RxCUI 645146 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Minoxidil
6984IN
-
Minoxidil
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Regoxidine
2264759BN -
Rogaine
225702BN
-
Regoxidine
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Minoxidil Topical Foam
645145SCDF -
Minoxidil Topical Product
1165359SCDG -
Minoxidil Topical Foam [Regoxidine]
2264761SBDF -
Minoxidil Topical Foam [Rogaine]
702353SBDF -
Regoxidine Topical Product
2264762SBDG -
Rogaine Topical Product
1181375SBDG -
Topical Foam
346285DF -
Topical Product
1151122DFG
-
Minoxidil Topical Foam
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Minoxidil 50 MG/ML
330042SCDC -
Minoxidil 50 MG/ML Topical Foam [Regoxidine]
2264763SBD -
Minoxidil 50 MG/ML Topical Foam [Rogaine]
702354SBD -
Minoxidil 50 MG/ML [Regoxidine]
2264760SBDC -
Minoxidil 50 MG/ML [Rogaine]
702352SBDC
-
Minoxidil 50 MG/ML
Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Minoxidil 50 MG/ML
SCDC · 330042 -
Minoxidil Topical Foam
SCDF · 645145 -
Minoxidil Topical Product
SCDG · 1165359
Brand-Name Concepts
-
Minoxidil 50 MG/ML Topical Foam [Regoxidine]
SBD · 2264763 -
Minoxidil 50 MG/ML Topical Foam [Rogaine]
SBD · 702354 -
Minoxidil 50 MG/ML [Regoxidine]
SBDC · 2264760 -
Minoxidil 50 MG/ML [Rogaine]
SBDC · 702352 -
Minoxidil Topical Foam [Regoxidine]
SBDF · 2264761 -
Minoxidil Topical Foam [Rogaine]
SBDF · 702353 -
Regoxidine Topical Product
SBDG · 2264762 -
Rogaine Topical Product
SBDG · 1181375 -
Regoxidine
BN · 2264759 -
Rogaine
BN · 225702
📦 FDA Products & Package NDCs
73 products · 121 package NDCs
121 package NDCs map to RxCUI 645146 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 81653-0007-01 | 1 BOTTLE in 1 PACKAGE (81653-007-01) / 60 mL in 1 BOTTLE | Regenivade Hair Growth Foam | Guangzhou Jianyuan Biological Technology.Co.,Ltd | 2023-10-23 |
| 82376-6006-03 | 3 CAN in 1 CARTON (82376-6006-3) / 60 g in 1 CAN (82376-600... | Minoxidil (For Men) | SPAZI INC. | 2022-08-30 |
| 82376-6007-02 | 2 CAN in 1 CARTON (82376-6007-2) / 60 g in 1 CAN (82376-600... | Minoxidil (For Women) | SPAZI INC. | 2022-08-30 |
| 82796-0100-01 | 1 CONTAINER in 1 BOX (82796-100-01) / 60 g in 1 CONTAINER | Minoxidil (for Men) | RESTORATION HOLDINGS, LLC | 2023-01-01 |
| 83804-0008-01 | 60 mL in 1 BOTTLE (83804-008-01) | HAIR GROWTH FOAM | Shenzhen Shandian Jingling Technology Co., Ltd. | 2025-08-22 |
| 84148-0025-01 | 60 g in 1 BOTTLE (84148-025-01) | 5% Minoxidil Hair Regrowth Foam | Guangzhou Ariel Biotech Co., Ltd. | 2026-04-02 |
| 84232-0012-21 | 1 BOTTLE, DISPENSING in 1 BOX (84232-012-21) / 60 g in 1 BO... | Hair Regen - Hair Regrowth Treatment | Yiwu Yizhou Trading Co., Ltd | 2025-04-15 |
| 84232-0014-26 | 6 BOTTLE, DISPENSING in 1 BOX (84232-014-26) / 60 g in 1 BO... | Hair Regen - Hair Regrowth Treatment | Yiwu Yizhou Trading Co., Ltd | 2025-04-15 |
| 84232-0016-21 | 1 BOTTLE, DISPENSING in 1 BOX (84232-016-21) / 28.35 g in 1... | Hair Regen - Hair Regrowth Treatment | Yiwu Yizhou Trading Co., Ltd | 2025-04-15 |
| 84232-0018-26 | 6 BOTTLE, DISPENSING in 1 BOX (84232-018-26) / 28.35 g in 1... | Hair Regen - Hair Regrowth Treatment | Yiwu Yizhou Trading Co., Ltd | 2025-04-15 |
| 84382-0001-04 | 1 CAN in 1 PACKAGE (84382-001-04) / 60 g in 1 CAN | Minoxidil | Clarity Cosmetics Inc. | 2026-06-01 |
| 85173-0001-01 | 60 mL in 1 BOTTLE (85173-001-01) | HAIR BEARDGROWTH FOAM | Shenzhen Xuemin E-commerce Co., Ltd. | 2025-01-16 |
| 85173-0001-02 | 80 mL in 1 BOTTLE (85173-001-02) | HAIR BEARDGROWTH FOAM | Shenzhen Xuemin E-commerce Co., Ltd. | 2025-01-16 |
| 85524-2611-02 | 3 BOTTLE in 1 BAG (85524-2611-2) / 60 g in 1 BOTTLE (85524-... | MINOXIDIL (FOR MEN) | FlexiGo Inc | 2026-06-08 |
| 85524-2612-02 | 1 BOTTLE in 1 BOX (85524-2612-2) / 60 g in 1 BOTTLE (85524-... | MINOXIDIL (FOR MEN) | FlexiGo Inc | 2026-06-14 |
| 85929-0101-18 | 3 CAN in 1 BOX (85929-101-18) / 60 g in 1 CAN | Gainxtra Hair Regrowth Treatment for Men and Women Minoxidil 5% Form with Biotin | GAINXTRA LLC | 2025-11-07 |
| 87086-0001-01 | 1 BOTTLE in 1 PACKAGE (87086-001-01) / 60 g in 1 BOTTLE | Carenice 5% Minoxidil HAIR REGROWTH TREATMENT | Shenzhen Yifusi Technology Co., Ltd. | 2025-09-08 |
| 87086-0001-02 | 2 BOTTLE in 1 PACKAGE (87086-001-02) / 60 g in 1 BOTTLE | Carenice 5% Minoxidil HAIR REGROWTH TREATMENT | Shenzhen Yifusi Technology Co., Ltd. | 2025-09-08 |
| 87086-0001-03 | 3 BOTTLE in 1 PACKAGE (87086-001-03) / 60 g in 1 BOTTLE | Carenice 5% Minoxidil HAIR REGROWTH TREATMENT | Shenzhen Yifusi Technology Co., Ltd. | 2025-09-08 |
| 87086-0001-04 | 4 BOTTLE in 1 PACKAGE (87086-001-04) / 60 g in 1 BOTTLE | Carenice 5% Minoxidil HAIR REGROWTH TREATMENT | Shenzhen Yifusi Technology Co., Ltd. | 2025-09-08 |
| 87086-0001-05 | 5 BOTTLE in 1 PACKAGE (87086-001-05) / 60 g in 1 BOTTLE | Carenice 5% Minoxidil HAIR REGROWTH TREATMENT | Shenzhen Yifusi Technology Co., Ltd. | 2025-09-08 |
Observed labelers:
Aurohealth LLC (10) ·
CVS Pharmacy (10) ·
P & L Development, LLC (10) ·
INNOVUS PHARMACEUTICALS, INC. (6) ·
Kenvue Brands LLC (6) ·
L. Perrigo Company (5)
· +31 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.